Afficher la notice abrégée

dc.creatorSpanos, K.en
dc.creatorGiannoukas, A. D.en
dc.date.accessioned2015-11-23T10:48:05Z
dc.date.available2015-11-23T10:48:05Z
dc.date.issued2015
dc.identifier10.1016/j.ejvs.2014.11.019
dc.identifier.issn1078-5884
dc.identifier.urihttp://hdl.handle.net/11615/33240
dc.source.uri<Go to ISI>://WOS:000352332500022
dc.subjectCOST-EFFECTIVENESSen
dc.subjectWARFARINen
dc.subjectSurgeryen
dc.subjectPeripheral Vascular Diseaseen
dc.titleRe: 'Kakkos et al. Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'en
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée